Interventional bundle for venous thromboembolism prevention: ensuring quality and effectiveness.
patient safety
pdsa
quality improvement
root cause analysis
Journal
BMJ open quality
ISSN: 2399-6641
Titre abrégé: BMJ Open Qual
Pays: England
ID NLM: 101710381
Informations de publication
Date de publication:
2019
2019
Historique:
received:
26
06
2018
revised:
27
05
2019
accepted:
01
06
2019
entrez:
13
7
2019
pubmed:
13
7
2019
medline:
13
7
2019
Statut:
epublish
Résumé
Hospital-associated thromboses (HATs) are a potentially preventable cause of morbidity and mortality. Oxford University Hospitals NHS Foundation Trust was designated a Venous Thromboembolism (VTE) Exemplar Centre by NHS England in 2014. However, following delayed reporting of a potentially preventable HAT in 2015, a benchmarking exercise suggested HATs were being under-reported, and also that the established hospital-wide audits of VTE prevention had significant limitations. The aim of this interventional bundle was to ensure high-quality data for key VTE prevention measures across the hospital, to identify areas for improvement and demonstrate a reduction in the number of potentially preventable HATs over a 2-year period. The project team engaged with hospital leadership and collaborated with hospital-wide stakeholders. A multifaceted approach was taken and 'Plan Do Study Act' cycles were used to test interventions with continuous evaluation of impact. The percentage of inpatients receiving appropriate thromboprophylaxis progressively increased from 94% to 98%. The project did not achieve its secondary aim of a reduction in the number of potentially preventable HATs. Revision of the HAT reporting process resulted in better detection and an initial increase in reporting of potentially preventable HATs, although data suggest that the level of harm from errors is now reducing. The improvement in overall appropriate thromboprophylaxis is considered to be due to robust audits of appropriate thromboprophylaxis, upskilling of ward pharmacists, improved detection of potentially preventable HATs resulting in additional safety nets such as linking the 'outcome recommendation' of the electronic VTE risk assessment directly to electronic prescribing, and increased awareness and education. Combining low-cost actions in a coordinated interventional bundle has produced measurable improvements in our VTE management programme, enhancing patient safety. We believe the model to be sustainable and replicable in other general hospitals.
Identifiants
pubmed: 31297454
doi: 10.1136/bmjoq-2018-000459
pii: bmjoq-2018-000459
pmc: PMC6590969
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e000459Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMJ Qual Improv Rep. 2016 Dec 20;5(1):
pubmed: 28090329
Blood Coagul Fibrinolysis. 2014 Sep;25(6):571-6
pubmed: 24686103
Br J Haematol. 2019 Sep;186(5):792-793
pubmed: 31168834
BMJ. 2012 Jun 19;344:e3935
pubmed: 22718994
Heart. 2013 Dec;99(23):1734-9
pubmed: 24038168
Chest. 2013 Oct;144(4):1276-1281
pubmed: 23681495
Chest. 2008 Jun;133(6 Suppl):381S-453S
pubmed: 18574271
Br J Haematol. 2017 Jul;178(1):162-170
pubmed: 28542789
J Thromb Haemost. 2017 Nov;15(11):2138-2146
pubmed: 28836340
Arch Intern Med. 2002 Jun 10;162(11):1245-8
pubmed: 12038942
J Hosp Med. 2010 Jan;5(1):10-8
pubmed: 19753640
BMJ Qual Improv Rep. 2016 Nov 22;5(1):
pubmed: 27933145